Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

NSC 286193

 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2004
2004
SummaryTiazofurin (2-β-D-ribofuranosylthiazole-4-carboxamide, TCAR) is a synthetic C-nucleoside that demonstrated significant in… Expand
  • table 1
  • table 2
  • table 3
  • table 4
  • figure 1
Is this relevant?
1990
1990
A phase I trial of 2-beta-D-ribofuranosylthiazole-4-carboxamide (NCS 286193, tiazofurin) was conducted using a 5-day i.v. bolus… Expand
Is this relevant?
1989
1989
Tiazofurin (2-beta-D-ribofuranosylthiazole-4-carboxamide, NSC 286193), a selective inhibitor of the activity of IMP dehydrogenase… Expand
  • figure I
  • table 1
  • figure 2
  • figure 3
  • table 2
Is this relevant?
1988
1988
Tiazofurin (2-beta-D-ribofuranosyl-4-thiazole-carboxamide; NSC 286193), an antitumor carbon-linked nucleoside that inhibits IMP… Expand
  • figure 2
  • figure 4
  • figure 5
  • figure 6
  • figure 7
Is this relevant?
1987
1987
A patient with refractory acute myeloid leukemia was treated with tiazofurin, an agent that causes inhibition of tumor cell… Expand
  • figure 1
Is this relevant?
1986
1986
SummaryA phase I and pharmacokinetic study of tiazofurin (NSC 286193), a C-nucleoside that inhibits IMP dehydrogenase, has been… Expand
  • table 1
  • table 2
  • table 3
  • table 4
Is this relevant?
1985
1985
Tiazofurin (2-beta-D-ribofuranosylthiazole-4-carboxamide, TCAR, Riboxamide, NSC 286193) is a novel C-nucleoside with antitumor… Expand
Is this relevant?
1985
1985
A Phase I trial of 2-beta-D-ribofuranosylthiazole-4-carboxamide (NSC 286193, tiazofurin) was conducted using a 5-day continuous… Expand
Is this relevant?
1982
1982
Abstract Studies on the mechanism of action of a new oncolytic nucleoside, 2-β- d -ribofuranosylthiazole-4-carboxamide, have been… Expand
Is this relevant?
1982
1982
Administration of the novel thiazole C-nucleoside, 2-beta-D-ribofuranosylthiazole-4-carboxamide (NSC 286193), to BDF1 mice… Expand
Is this relevant?